Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome.
D000293:Adolescent; D000328:Adult; D001706:Biopsy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007248:Infertility, Male / Q000139:chemically induced; D007668:Kidney / Q000473:pathology; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D011627:Puberty; D012661:Semen; D013091:Spermatogenesis / Q000187:drug effects; D013737:Testis / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D013739:Testosterone / Q000097:blood
D013739:Testosterone; D003520:Cyclophosphamide; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone